Table 2.

In vivo tumor formation ability of T-p53Rb cells sorted according to Sca1 expression

Cell type*Tumors/miceTumor weight (g ± SD)Histologic analysis
Unsorted4/40.719 ± 0.16Leiomyosarcoma
Sca1−7/70.675 ± 0.26Leiomyosarcoma
Sca1+7/70.820 ± 0.56Leiomyosarcoma
  • *Cells (2 × 105) were inoculated into NOD-SCID mice.

  • All mice were sacrificed 15 days after inoculation.

  • *Cells (2 × 105) were inoculated into NOD-SCID mice.

  • All mice were sacrificed 15 days after inoculation.